血管生理学部
研究業績
- Ishibashi T, Nakaoka Y. Biomarkers for Takayasu arteritis: Which is the most promising? International Journal of Cardiology. 371, 418-419, 2023.
- Konagai N, Kamiya CA, Nakanishi A, Iwanaga N, Sawada M, Kakigano A, Kanagawa T, Eto S, Nishida Y, Nakaoka Y, Yoshimatsu J. Safe use of tocilizumab in pregnant women with Takayasu arteritis: three case studies. RMD Open. 9, e002996, 2023.
- Sugihara T, Uchida HA, Yoshifuji H, Maejima Y, Naniwa T, Katsumata Y, Okazaki T, Ishizaki J, Murakawa Y, Ogawa N, Dobashi H, Horita T, Tanaka Y, Furuta S, Takeuchi T, Komagata Y, Nakaoka Y, Harigai M. Association between the patterns of large-vessel lesions and treatment outcomes in patients with large-vessel giant cell arteritis. Modern Rheumatology. 33, 1145-1153, 2023.
- Saito S, Suzuki K, Ohtani R, Maki T, Kowa H, Tachibana H, Washida K, Kawabata N, Mizuno T, Kanki R, Sudoh S, Kitaguchi H, Shindo K, Shindo A, Oka N, Yamamoto K, Yasuno F, Kakuta C, Kakuta R, Yamamoto Y, Hattori Y, Takahashi Y, Nakaoku Y, Tonomura S, Oishi N, Aso T, Taguchi A, Kagimura T, Kojima S, Taketsuna M, Tomimoto H, Takahashi R, Fukuyama H, Nagatsuka K, Yamamoto H, Fukushima M, Ihara M; COMCID Trial Investigator Group. Efficacy and Safety of Cilostazol in Mild Cognitive Impairment: A Randomized Clinical Trial. JAMA Network Open. 6, e2344938, 2023.
- Ikeda S, Saito S, Hosoki S, Tonomura S, Yamamoto Y, Ikenouchi H, Ishiyama H, Tanaka T, Hattori Y, Friedland RP, Carare RO, Kuriyama N, Yakushiji Y, Hara H, Koga M, Toyoda K, Nomura R, Takegami M, Nakano K, Ihara M. Harboring Cnm-expressing Streptococcus mutans in the oral cavity relates to both deep and lobar cerebral microbleeds. European Journal of Neurology. 30, 3487-3496, 2023.
- Tsuji A, Miyata T, Sekine A, Neki R, Kokame K, Tomita T, Kashima Y, Asano R, Ueda J, Aoki T, Ogo T. Three Cases of Unprovoked Venous Thromboembolism with Prothrombin p.Arg596Gln Variant and a Literature Review of Antithrombin Resistance. Internal Medicine. 62, 885-888, 2023.
- 殿村 修一, 猪原 匡史. 腸内細菌と脳卒中. 脳神経外科. 51, 169-176, 2023.